Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.8 Million Private Placement for Sharps Technology, Inc. (NASDAQ:STSS)
Sharps Technology, Inc. announced a successful $3.8 million private placement, with Aegis Capital Corp. serving as the exclusive placement agent. The company specializes in innovative drug delivery systems, focusing on low waste and ultra-low waste syringe technologies designed to enhance safety for healthcare workers and the public. With a manufacturing facility in Hungary and a partnership with Nephron Pharmaceuticals, Sharps Technology aims to expand its U.S. manufacturing capacity. This funding aims to bolster Sharps Technology's capabilities in producing prefilled syringe systems.
- Successful completion of a $3.8 million private placement.
- Partnership with Nephron Pharmaceuticals to enhance U.S. manufacturing capacity.
- Focus on innovative syringe technologies that improve healthcare worker safety.
- None.
NEW YORK, NY / ACCESSWIRE / February 6, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a
About Sharps Technology, Inc.
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. The company's product lines focus on low waste and ultra-low waste syringe technologies that incorporate both passive and active safety features. These features protect front line healthcare workers from life-threatening needle stick injuries and protect the public from needle re-use. Sharps Technology has extensive expertise in specialized prefilled syringe systems and ready to use processing. The company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the US.
For more information, please visit: https://sharpstechnology.com
About Aegis Capital Corporation
Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research and sales and trading services to institutional investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.
For more information about this offering or Investment Banking Services please email Banking@aegiscap.com or call (212) 813-1010.
Brokerage and investment advisory services are offered through Aegis Capital Corporation, a member of FINRA and SIPC. Investment and insurance products offered are not insured by the FDIC or any other federal government agency, are not deposits or other obligations of, or guaranteed by, a bank or any bank affiliate, and are subject to investment risks, including possible loss of the principal amount invested.
SOURCE: Aegis Capital Corp.
View source version on accesswire.com:
https://www.accesswire.com/738205/Aegis-Capital-Corp-Acted-as-Exclusive-Placement-Agent-on-a-38-Million-Private-Placement-for-Sharps-Technology-Inc-NASDAQSTSS
FAQ
What is the significance of Sharps Technology's $3.8 million private placement?
Who acted as the placement agent for Sharps Technology's private placement?
What are the main products of Sharps Technology?
What partnership does Sharps Technology have to expand manufacturing?
